[Iatrogenic central serous chorioretinopathy during glucocorticoid therapy for temporal arteritis]

Rev Med Interne. 2006 Sep;27(9):702-5. doi: 10.1016/j.revmed.2006.06.002. Epub 2006 Jun 27.
[Article in French]

Abstract

Introduction: Visual complications of temporal arteritis are frequent and serious. Their risk prompts glucocorticoid therapy, but this treatment may also cause ophthalmologic troubles.

Exegesis: A sudden and isolated monocular visual blur, occurring in a 66 years old woman after 4 month of glucocorticoid treatment for temporal arteritis, revealed a case of iatrogenic central serous chorioretinopathy. The diagnosis of this disease is established by fluorescein angiography and its functional prognosis is excellent. Tapering the doses of glucocorticoids, as fast as the underlying disease allows, hastens visual recovery.

Conclusion: When the treatment of temporal arteritis is commenced for more than a month, new visual complications are rare. Central serous chorioretinopathy induced by glucocorticoids belongs to the diagnoses that should be evoked in this case, especially if there is no clinical manifestation of arteritis and no inflammatory markers.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects*
  • Chorioretinitis / chemically induced*
  • Female
  • Fluorescein Angiography
  • Giant Cell Arteritis / drug therapy*
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects*
  • Humans
  • Iatrogenic Disease
  • Prednisolone / administration & dosage
  • Prednisolone / adverse effects*
  • Prognosis
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Prednisolone